CT-P6 compared with reference trastuzumab for HER2-positive breast cancer: a randomised, double-blind, active-controlled, phase 3 equivalence trial
Justin Stebbing(Imperial College London), Y. Baranau(9th City Clinical Hospital), Valeriy Baryash(Belarusian State Medical University), Alexey Manikhas(City Clinical Oncology Center), Vladimir Moiseyenko(State Budget Institution of Health St. Petersburg Clinical Research Center Specialized Types of Medical Care), Giorgi Dzagnidze, Edvard Zhavrid(N.N. Alexandrov National Cancer Centre), Dmytro Boliukh(Kyiv City Clinical Oncology Center), Daniil Stroyakovskii(Moscow City Oncology Hospital №62), Joanna Pikiel(Centrum Onkologii), Alexandru Eniu(Institute of Oncology Prof. Dr. Ion Chiricuta), Д. В. Комов(Russian Cancer Research Center NN Blokhin), Gabriela Morar-Bolba(Institute of Oncology Prof. Dr. Ion Chiricuta), Rubi K. Li(St. Luke's Medical Center), Andriy Rusyn, Sang Joon Lee(Celltrion (South Korea)), Sungyoung Lee(Celltrion (South Korea)), Francisco J. Esteva(NYU Langone Health)
Cited by 123Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis